Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ADVM

Adverum Biotechnologies

$5.04

-0.19 (-3.63%)

, EDIT

Editas Medicine

$29.60

0.49 (1.68%)

16:14
10/17/18
10/17
16:14
10/17/18
16:14
Hot Stocks
Adverum Biotechnologies promotes Leone Patterson to CEO »

Adverum Biotechnologies…

ADVM

Adverum Biotechnologies

$5.04

-0.19 (-3.63%)

EDIT

Editas Medicine

$29.60

0.49 (1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
EDIT

Editas Medicine

$27.76

-0.13 (-0.47%)

16:34
10/09/18
10/09
16:34
10/09/18
16:34
Initiation
Editas Medicine initiated at Guggenheim »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

EDIT

Editas Medicine

$27.53

-1 (-3.51%)

, NTLA

Intellia Therapeutics

$23.99

-0.39 (-1.60%)

11:59
10/08/18
10/08
11:59
10/08/18
11:59
Periodicals
Scientists use CRISPR to cure mice disorder in womb, STAT reports »

Scientists reported today…

EDIT

Editas Medicine

$27.53

-1 (-3.51%)

NTLA

Intellia Therapeutics

$23.99

-0.39 (-1.60%)

CRSP

Crispr Therapeutics

$36.37

-2.18 (-5.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

EDIT

Editas Medicine

$29.00

-1.245 (-4.12%)

10:25
10/04/18
10/04
10:25
10/04/18
10:25
Conference/Events
Editas Medicine participates in a conference call with JPMorgan »

JPMorgan Large Cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

EDIT

Editas Medicine

$30.24

1.11 (3.81%)

04:55
10/04/18
10/04
04:55
10/04/18
04:55
Conference/Events
Editas Medicine participates in a conference call with JPMorgan »

JPMorgan Large Cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

EDIT

Editas Medicine

$30.09

-0.39 (-1.28%)

10:19
10/02/18
10/02
10:19
10/02/18
10:19
Conference/Events
Editas Medicine participates in a conference call with JPMorgan »

JPMorgan Large Cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

EDIT

Editas Medicine

$32.55

-0.64 (-1.93%)

07:45
09/21/18
09/21
07:45
09/21/18
07:45
Initiation
Editas Medicine initiated at Raymond James »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EDIT

Editas Medicine

$32.55

-0.64 (-1.93%)

16:43
09/20/18
09/20
16:43
09/20/18
16:43
Initiation
Editas Medicine initiated at Raymond James »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
SGMO

Sangamo

$14.60

0.85 (6.18%)

, EDIT

Editas Medicine

$31.03

0.77 (2.54%)

16:05
09/10/18
09/10
16:05
09/10/18
16:05
Periodicals
Study finds rolled up genes can't be edited by CRISPR, STAT reports »

A scientific study found…

SGMO

Sangamo

$14.60

0.85 (6.18%)

EDIT

Editas Medicine

$31.03

0.77 (2.54%)

CRSP

Crispr Therapeutics

$49.58

-0.61 (-1.22%)

NTLA

Intellia Therapeutics

$26.97

-0.26 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 27

    Sep

EDIT

Editas Medicine

$30.49

0.23 (0.76%)

14:18
09/10/18
09/10
14:18
09/10/18
14:18
Hot Stocks
Editas 'pleased' U.S. appeals court affirmed favorable USPTO decision »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.